These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23623327)

  • 1. Implantation of CD133(+) stem cells in patients undergoing coronary bypass surgery.
    Kopjar T; Biocina B; Cepulic BG; Milicic D
    Can J Cardiol; 2013 Nov; 29(11):1533.e1. PubMed ID: 23623327
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to letter from Kopjar et al.-the IMPACT-CABG Pilot Trial.
    Noiseux N; Stevens LM; Prieto I; Salem R; Roy DC; Larose E; Mansour S
    Can J Cardiol; 2013 Nov; 29(11):1533.e3. PubMed ID: 23725864
    [No Abstract]   [Full Text] [Related]  

  • 3. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
    Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
    Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addendum to 'Intraoperative CD133+ cell transplantation during coronary artery bypass grafting in ischemic cardiomyopathy'†.
    Klein HM; Assmann A; Heke M
    Multimed Man Cardiothorac Surg; 2014 Jul; 2014():. PubMed ID: 24994660
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical labeling and imaging of transplanted CD133+/CD34+ stem cells in patients with ischemic heart disease.
    Ghodsizad A; Bordel V; Bruckner B; Loebe M; Fuerst G; Mirsaidi I; Sucker M; Ruhparwar A; Karck M; Klein HM
    Heart Surg Forum; 2012 Apr; 15(2):E116-18. PubMed ID: 22543333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
    Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
    Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution.
    Goussetis E; Manginas A; Koutelou M; Peristeri I; Theodosaki M; Kollaros N; Leontiadis E; Theodorakos A; Paterakis G; Karatasakis G; Cokkinos DV; Graphakos S
    Stem Cells; 2006 Oct; 24(10):2279-83. PubMed ID: 16794269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
    Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery".
    D'Amario D; Leone AM; Iaconelli A; Luciani N; Gaudino M; Kannappan R; Manchi M; Severino A; Shin SH; Graziani F; Biasillo G; Macchione A; Smaldone C; Cellini C; Siracusano A; Ottaviani L; Massetti M; Goichberg P; Leri A; Anversa P; Crea F
    Circulation; 2014 Sep; 130(13):e118-9. PubMed ID: 25245852
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter by Li and Shen regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery".
    Li Y; Shen Z
    Circulation; 2014 Sep; 130(13):e117. PubMed ID: 25245851
    [No Abstract]   [Full Text] [Related]  

  • 11. Predicting the future with stem cells.
    Mohsin S; Wu JC; Sussman MA
    Circulation; 2014 Jan; 129(2):136-8. PubMed ID: 24249719
    [No Abstract]   [Full Text] [Related]  

  • 12. Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium.
    Suzuki G; Iyer V; Lee TC; Canty JM
    Circ Res; 2011 Oct; 109(9):1044-54. PubMed ID: 21885831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.
    Donndorf P; Kundt G; Kaminski A; Yerebakan C; Liebold A; Steinhoff G; Glass A
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):911-20. PubMed ID: 21376346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease.
    Caveliers V; De Keulenaer G; Everaert H; Van Riet I; Van Camp G; Verheye S; Roland J; Schoors D; Franken PR; Schots R
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):61-6. PubMed ID: 17372574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
    Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
    Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
    Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
    Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
    Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.
    Maruskova M; Gregor P; Bartunek J; Tintera J; Penicka M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):62-8. PubMed ID: 19577058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results.
    Pompilio G; Steinhoff G; Liebold A; Pesce M; Alamanni F; Capogrossi MC; Biglioli P
    Thorac Cardiovasc Surg; 2008 Mar; 56(2):71-6. PubMed ID: 18278680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.